The first look at Turning Point’s TPX-0022 shows signs of activity beyond cMet inhibitors’ proven use in lung cancer.
The German group hopes that boosting its presence in gene therapy will drive growth of its pharma business.
Moderna battles Pfizer/Biontech to generate the first pivotal study data for a Covid-19 vaccine.
Details are scant about the “unexplained illness” seen with Johnson & Johnson’s Covid-19 vaccine, but the news puts another dent in public confidence.
With the EU regulator already reviewing two coronavirus vaccines, could it beat the US FDA to the punch?
October brings US approval decisions for Eysuvis and Brilinta, while a panel meeting sets up a discussion around Covid-19 vaccines.